Alphyn Biologics, Inc.
Steven Pentelnik has a diverse work experience spanning over several decades. Steven started their career at Procter & Gamble in 1977, where they held the position of Associate Director for an impressive 35 years. In 2010, they became a Board Member at the Jewish Federation, a role they held until 2014. In 2012, they joined Enermatix as an Executive Vice President, and then moved on to Opticare, LLC in 2014, where they served as Chief Executive Officer until 2016. From 2016 to 2018, they worked as the Executive Vice President at Nanohealth USA. Currently, they hold the position of President at Alphyn Biologics, LLC since 2019. It is evident that Steven Pentelnik not only has extensive experience, but has also held leadership roles across various industries.
Steven Pentelnik attended Wayne State University from 1972 to 1977, where they pursued a Bachelor's degree in Chemical Engineering.
This person is not in any teams
This person is not in any offices
Alphyn Biologics, Inc.
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.